Cocrystal Pharma, Inc. (COCP)
1.15
+0.01
(+0.88%)
USD |
NASDAQ |
Sep 18, 09:43
Cocrystal Pharma Cash from Operations (Quarterly) : -2.536M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.536M |
| March 31, 2026 | -2.34M |
| December 31, 2025 | -1.836M |
| September 30, 2025 | -1.551M |
| June 30, 2025 | -2.268M |
| March 31, 2025 | -2.939M |
| December 31, 2024 | -2.550M |
| September 30, 2024 | -4.310M |
| June 30, 2024 | -3.638M |
| March 31, 2024 | -4.503M |
| December 31, 2023 | -2.864M |
| September 30, 2023 | -3.051M |
| June 30, 2023 | -5.785M |
| March 31, 2023 | -3.111M |
| December 31, 2022 | -5.300M |
| September 30, 2022 | -8.896M |
| June 30, 2022 | -3.809M |
| March 31, 2022 | -3.91M |
| December 31, 2021 | -2.596M |
| September 30, 2021 | -5.405M |
| June 30, 2021 | -2.662M |
| March 31, 2021 | -1.77M |
| December 31, 2020 | -3.014M |
| September 30, 2020 | -3.188M |
| June 30, 2020 | -1.893M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.188M |
| December 31, 2019 | -1.232M |
| September 30, 2019 | -1.323M |
| June 30, 2019 | -1.026M |
| March 31, 2019 | 2.018M |
| December 31, 2018 | -1.692M |
| September 30, 2018 | -2.254M |
| June 30, 2018 | -2.020M |
| March 31, 2018 | -2.078M |
| December 31, 2017 | -1.193M |
| September 30, 2017 | -2.401M |
| June 30, 2017 | -1.234M |
| March 31, 2017 | -2.052M |
| December 31, 2016 | -1.827M |
| September 30, 2016 | -2.781M |
| June 30, 2016 | -5.151M |
| March 31, 2016 | -4.042M |
| December 31, 2015 | -2.925M |
| September 30, 2015 | -2.815M |
| June 30, 2015 | -2.480M |
| March 31, 2015 | -1.559M |
| December 31, 2014 | -1.510M |
| September 30, 2014 | -1.107M |
| June 30, 2014 | -1.366M |
| March 31, 2014 | -1.78M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.0477M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -48.30M |
| Fulcrum Therapeutics, Inc. | -16.04M |
| Definium Therapeutics, Inc. | -52.33M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -8.276M |
| Free Cash Flow Per Share (Quarterly) | -0.1839 |
| Free Cash Flow to Equity (Quarterly) | -2.453M |
| Free Cash Flow to Firm (Quarterly) | -2.536M |
| Free Cash Flow Yield | -54.99% |